Organisation paid for research Program year 2025 Source: CMS Open Payments

MPX Group

Neither a doctor nor a teaching hospital

Research payments

$94,266

3,041 payments

Through program year 2025, MPX Group is reported as receiving $94,266 in research payments, across 3,041 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$14,293	445
2024	Research	$15,401	435
2023	Research	$13,669	442
2022	Research	$12,066	418
2021	Research	$23,369	829
2020	Research	$15,468	472

Breakdown

Who paid Research payments · program years 2020–2025

Abbott Laboratories $94,266 3,041 payments

Studies the money was for Research payments · program years 2020–2025

Clinical TRIal to EvaLUate Cardiovascular OutcoMes IN PAtients Treated with the Tricuspid ValvE Repair System Pivotal $4,467 143 payments
Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants (CATALYST) $4,368 117 payments
CATALYST IDE Study $4,165 141 payments
NCT05932615--ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation $3,486 117 payments
Antiplatelet Removal and HemocompatIbility EventS in the HeartMate 3 Pump $3,361 131 payments
Clinical TRIal to EvaLUate Cardiovascular OutcoMes IN PAtients Treated with the Tricuspid ValvE Repair System Pivotal $3,178 42 payments
VOLT-AF IDE Clinical Study $2,907 45 payments
Distinct $2,514 67 payments
NCT06707688--Abbott Medical - VERITAS Study $2,512 61 payments
Percutaneous MitraClipTM Device or Surgical Mitral Valve REpair in PAtients with PrImaRy MItral Regurgitation who are Candidates for Surgery (REPAIR MR) $2,498 79 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.